Clinical Trial Update: Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Atazanavir-based regimens with ritonavir, saquinavir, or lopinavir/ritonavir, each combined with tenofovir and a nucleoside, in HIV inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Invirase (saquinavir)
• Kaletra (lopinavir)
• Norvir (ritonavir)
• REYATAZ (atazanavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-12-24